Aldeyra Therapeutics to Present at the 2016 SSADH Symposium
Mar 24, 2016 12:30 pm UTC| Business
LEXINGTON, Mass., March 24, 2016 -- Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehydes, today announced that David...
Recro Pharma Reports Year End 2015 Financial Results
Mar 24, 2016 12:20 pm UTC| Business
MALVERN, Pa., March 24, 2016 -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment of serious acute pain, today reported...
Mar 24, 2016 12:15 pm UTC| Business
NEW YORK and MELBOURNE, Australia, March 24, 2016 -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that the United States Patent and Trademark Office has granted a key patent covering the use of the...
ObsEva Strengthens Board with Appointment of Biotechnology Veteran Dr. Frank Verwiel
Mar 24, 2016 12:09 pm UTC| Business
GENEVA, March 24, 2016 -- ObsEva, a Swiss biopharmaceutical company innovating women's reproductive health and pregnancy therapeutics, today announced the appointment of Frank Verwiel, MD to its Board of Directors. Over...
Emisphere Announces 2015 Earnings Conference Call
Mar 24, 2016 12:00 pm UTC| Business
ROSELAND, N.J., March 24, 2016 -- Emisphere (OTCQB:EMIS) announced today that management will host a conference call to discuss the Company's financial and operational results for the twelve months ended December 31,...
Mar 24, 2016 12:00 pm UTC| Business
BERKELEY, Calif., March 24, 2016 -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced that the first patient has been dosed in SEASCAPE, the Phase 1/2 clinical study designed to evaluate the safety, tolerability and...
Mar 24, 2016 12:00 pm UTC| Business
SAN DIEGO, March 24, 2016 -- Retrophin, Inc.(NASDAQ:RTRX) today announced that four abstracts related to the development of RE-024, the company’s novel investigational replacement therapy for pantothenate...